Perennial allergic rhinitis in the course of grass pollen allergy. Case discussion

Main Article Content

Agnieszka Lipiec
Piotr Rapiejko

Abstract

Over 8 million people in Poland suffer from allergic rhinitis. Grass pollen allergens are the most common cause of the disease. In Poland the sufferers are exposed to airborne grass pollen allergens for a few months. The threshold grass pollen count, that is necessary to evoke symptoms in the majority of grass pollen allergy sufferers (20 grass pollen grains in 1 m3) is recorded for several dozen days yearly. It leads to the exposure that is persistent. Intranasal corticosteroids are considered the first line drugs for moderate and severe intermittent allergic rhinitis and for all stages of persistent rhinitis. The paper presents the case of an 20yearold man with symptoms of persistent allergic rhinitis in the course of grass pollen allergy.

Downloads

Download data is not yet available.

Article Details

How to Cite
Lipiec , A., & Rapiejko , P. (2014). Perennial allergic rhinitis in the course of grass pollen allergy. Case discussion. Alergoprofil, 10(2), 62-66. Retrieved from https://journalsmededu.pl/index.php/alergoprofil/article/view/805
Section
Article

References

1. Rapiejko P.: Alergeny pyłku roślin. Medical Education, Warszawa 2012.
2. Rapiejko P., Stankiewicz W., Szczygielski K. et al.: Progowe stężenia pyłku roślin niezbędne do wywołania objawów alergicznych. Otolaryngol. Pol. 2007; 61(4): 591-594.
3. Samoliński B., Arcimowicz M. et al.: Polskie Standardy Leczenia Nieżytów Nosa – PoSLeNN. Alergologia Polska 2013; nr specjalny S1.
4. Bousquet J., Van Cauwenberge P., Khaltaev N.; Aria Workshop Group; World Health Organization: Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 2001; 108: S147-334.
5. Rapiejko P.: Alergiczny nieżyt nosa. W: Alergologia kompendium. Pawliczak R. (red.). Termedia, Poznań 2013: 119-134.
6. Samoliński B., Nowicka A., Wojas O. et al.: Intranasal glucocorticosteroids - not only in allergic rhinitis in the 40th anniversary of intranasal glucocorticosteroids’ introduction. Otolaryngol. Pol. 2014; 68(2): 51-64.
7. Roberts G., Xatzipsalti M., Borrego L.M. et al.: Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy 2013; 68(9): 1102-16.